[144] Cellebrite DI Ltd. SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Cellebrite DI Ltd. (CLBT) reports a proposed sale of 40,535 common shares held as restricted stock units acquired on 02/15/2023. The filing lists Morgan Stanley Smith Barney LLC as the broker and an approximate aggregate market value of $728,413.95 with an expected sale date of 09/23/2025 on NASDAQ. The filer represents they are unaware of any undisclosed material adverse information. The filing also discloses 10b5-1 sales executed on 09/22/2025 totaling 25,810 shares for gross proceeds of $464,610.97. The issuer’s total shares outstanding are stated as 244,469,106.

Insights

Securities Analyst

TL;DR: Insider plans to sell a modest block of restricted stock units; prior 10b5-1 sales also disclosed.

The filing documents a proposed sale of 40,535 common shares acquired as restricted stock units and scheduled with Morgan Stanley Smith Barney. The disclosed aggregate market value is $728,413.95 against an outstanding share base of 244,469,106, indicating the position is small relative to total capitalization. The filing also confirms a 10b5-1 sale of 25,810 shares on 09/22/2025 for $464,610.97. The signer attests no undisclosed material adverse information. For investors, this is a routine insider liquidity event rather than a corporate action.

Corporate Governance Specialist

TL;DR: Disclosure meets Rule 144 and 10b5-1 notice requirements; no governance red flags in the text provided.

The document provides required details: acquisition date (02/15/2023), nature of acquisition (Restricted Stock Units), broker details, intended sale date (09/23/2025), and prior 10b5-1 sales. The signer’s representation about lacking material nonpublic information is included, as expected. There are no statements here about executive departures, related-party transactions, or regulatory issues. As presented, the filing appears procedural and compliant with disclosure norms.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40535	728413.95	244469106	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2023	Restricted Stock Units	Issuer			40535	02/15/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for RONNEN ARMON 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	COMMON	09/22/2025	25810	464610.97

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CLBT disclose?

The form discloses a proposed sale of 40,535 common shares acquired as restricted stock units on 02/15/2023, brokered by Morgan Stanley Smith Barney, with an aggregate market value of $728,413.95 and an approximate sale date of 09/23/2025.

Were any recent insider sales reported for CLBT?

Yes, the filing reports 10b5-1 sales executed on 09/22/2025 of 25,810 shares generating gross proceeds of $464,610.97.

How many CLBT shares are outstanding per the filing?

The filing states 244,469,106 shares outstanding.

What type of acquisition created the shares being sold?

The shares were acquired as Restricted Stock Units on 02/15/2023 from the issuer.

Which broker is handling the proposed CLBT sale?

The broker named is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.